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Abstract
Background: Pseudomyogenic hemangioendothelioma is a rare soft tissue tumor usually found in young adults,
predominantly males. Fibrous dysplasia is a common benign bone tumor, which accounts for 5~7 % of all the
primary benign bone tumors. However, pseudomyogenic hemangioendothelioma secondary to fibrous dysplasia
is extremely rare. To the best of our knowledge, this is the first case of pseudomyogenic hemangioendothelioma
secondary to fibrous dysplasia.
Case presentation: This study describes a case of a 14-year-old female who suffered from pseudomyogenic
hemangioendothelioma secondary to fibrous dysplasia of the left lower extremity. The patient underwent two
operations successively due to pathological fractures in the left femur and tibia in a local hospital. She was
diagnosed with fibrous dysplasia according to the postoperative pathological examinations. However, less than
1 year later, she was diagnosed with a recurrence of fibrous dysplasia in her left femur during a follow-up in our
hospital. She underwent a curettage and grafting in the left femur. Postoperative pathological examinations
demonstrated the diagnosis of fibrous dysplasia. Nevertheless, she presented to our clinic with a chief complaint
of pain and swelling in her left tibia and calcaneus 4 months later. The patient underwent fine-needle aspiration in
her left tibia. According to the histological and immunohistochemical findings, the diagnosis of pseudomyogenic
hemangioendothelioma was confirmed by an expert pathology consultant. Finally, the patient had to undergo an
amputation of the left thigh. Postoperative pathological examinations confirmed the diagnosis of pseudomyogenic
hemangioendothelioma. Postoperative follow-up at 3 months disclosed no evidence of recurrent disease and no
residual side effects from therapy.
Conclusions: Pseudomyogenic hemangioendothelioma is a rare endothelial neoplasm which often mimics myoid
and epithelioid tumors morphologically. For the diagnosis, the immunostaining is very important but not decisive
and enough. Analysis based on any single factor or incomplete information may easily lead to arbitrary conclusion.
Clinical information including age, gender, tumor location, disease course, and recurrence is important for
appropriate diagnosis, and full understanding of the tumor is indispensable.
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Background
Pseudomyogenic hemangioendothelioma (PMH), also
known as epithelioid sarcoma-like hemangioendothe-
lioma, occurs more frequently in young adult males and
usually arises in the extremities, especially on the lower
limb, and often involves multiple tissue planes [1–5]. In
the current WHO classification of soft tissue tumors,
PMH is listed as an intermediate, rarely metastasizing,
vascular tumor with peculiar clinical and pathological
features [5]. Fibrous dysplasia (FD) is a benign bone lesion
that is characterized by the replacement of portions of the
normal bone by fibrous connective tissue and poorly
formed trabecular bone. Monostotic and polyostotic forms
exist. Malignant degeneration is very unusual. The most
commonly observed malignant transformations are osteo-
sarcoma, fibrosarcoma, and chondrosarcoma [6]. To the
best of our knowledge, this is the first case of PMH
secondary to FD. The present study describes the case of a
PMH forming secondary to a FD in the left lower limb in
a 14-year-old female patient. This study was approved
by the ethical review committee of The First Affiliated
Hospital of Nanchang University Medical School, and
informed consent was obtained from the patient.
Case presentation
A 14-year-old female attended the Orthopedic Oncology
Clinic at The First Affiliated Hospital of Nanchang
University (Nanchang, China) for a follow-up. She
underwent two operations successively due to patho-
logical fractures in the left femur and tibia in a local
hospital about 1 year ago. Then, she was diagnosed
with FD according to the postoperative pathological
examinations. Recently, she had no obvious symptoms
and discomfort. Physical examinations showed nothing
remarkable, but a little swelling in her left distal thigh.
She had a negative family history of bone tumor. There
was no fever or respiratory embarrassment accompany-
ing the swelling. No history of weight loss or exposure
to tuberculosis was mentioned.
In a further examination, physical examination showed
no palpable head, neck, supraclavicular, axillary, or epi-
trochlear lymph nodes. Inflammatory markers were
within the normal limits. Plain radiographs indicated an
expansile osteolytic lesion with marginal sclerosis and a
matrix with a ground glass appearance and without peri-
osteal reaction of the left distal femur, which was con-
sistent with FD (Fig. 1a). Then, a diagnosis of recurrence
of FD in the left femur was made given the medical
history of FD, symptoms, and imaging findings.
Based on the exclusion of surgical contraindications,
professional surgeons, who specialized in treating bone
tumors, performed the surgery of curettage and grafting
in the left femur. Histologic analysis of hematoxylin and
eosin-stained specimens showed irregularly shaped spic-
ules of immature bone without osteoblastic rimming
and fibrous stroma with few mitotic activities (Fig. 2a).
Immunohistochemical analysis showed positive for CD68
and Vim but negative for bcl-2, CK, CD34, CD99, EMA,
SMA, and S100. According to the above findings, the
diagnosis of the recurrence of FD of the left femur was
finally confirmed.
Nevertheless, she presented to our clinic again with a
chief complaint of pain and swelling in her left tibia and
calcaneus 4 months later. Radiographic review showed a
Fig. 1 a Plain radiographs indicated an expansile osteolytic lesion with marginal sclerosis and a matrix with a ground glass appearance and without
periosteal reaction of the left distal femur. b Radiographic review showed a prominent osteolytic lesion located in the distal portion of the tibia and
calcaneus with cortical destruction
Ye et al. World Journal of Surgical Oncology  (2016) 14:198 Page 2 of 5
prominent osteolytic lesion located in the distal portion
of the tibia and calcaneus with cortical destruction
(Fig. 1b). The patient underwent surgery with the
removal of the tumor tissue and reconstruction with
allogenous bone graft. According to the histological
and immunohistochemical findings, the diagnosis of
PMH secondary to FD was confirmed by an expert
pathology consultant.
Finally, the patient had to undergo an amputation of
the left thigh. The tumor consisted of densely distributed
pleomorphic cells, ranging in configuration from small
spindled elements to large plump epithelioid variants
with prominent pink cytoplasm. Scattered cells with vac-
uolated cytoplasm were also present. Prominent pleo-
morphic nuclei contained optically empty centers with
peripheral marginalization of the chromatin, in addition
to conspicuous nucleoli. Multinucleated cells were also
present. Vasoformative elements, such as multi-cellular
vascular channels or intracytoplasmic vacuoles, were
identified (Fig. 2b). Immunohistochemical analysis showed
positive for CK, CD31 (Fig. 2c), but negative for s-100
and CD34. According to the above findings, the diagno-
sis of PMH secondary to FD of the left lower limb was
finally confirmed.
The patient was discharged without any complications
1 week after the amputation. At the time of the 3-month
follow-up, the patient reported no pain or discomfort in
her left lower extremity. No evidence of recurrence or
distal metastasis was noted during the 3 months after
surgery. However, it is necessary to perform continuous
observations of the patient because of a high rate of
recurrence and metastasis.
Discussion
Pseudomyogenic hemangioendothelioma is a rare soft tissue
tumor—distinct from epithelioid hemangioendothelioma
[7]—originally described as a “fibroma-like variant of epi-
thelioid sarcoma” [8]; it has been recently concluded that
the “epithelioid sarcoma-like hemangioendothelioma” is
essentially the same pathological entity [4]. PMH affects
predominantly young males. The tumor is multifocal,
involving different tissue planes and, although, it shares
some histopathologic features with epithelioid sarcoma, it
has a different, spindle cell morphology with common
positivity for CD31, lack of CD34 reactivity, and intact
INI-1 immunoreactivity [2, 9].
By contrast, fibrous dysplasia (FD) is a common
tumor-like lesion characterized by solitary or multifocal
polyostotic intramedullary lesions [10]. It has a fre-
quency of 2.5 % for all bone lesions and 7 % for benign
bone tumors [11]. While any bone can be affected by
FD, the most common sites of the disease are the femur,
the tibia, the ribs, the skull, the facial bones, the
humerus, and the pelvis. Although many bones can be
affected at once, FD is not a disease that spreads from
one bone to another. Multiple affected bones are often
found unilaterally [12].
However, malignant transformation of FD is rare and
occurs in less than 1 % of the cases [13, 14]. The most
commonly observed malignant transformations are osteo-
sarcoma, fibrosarcoma, and chondrosarcoma [6]. As far as
we can see, the current case is the first case reported ever
of PMH secondary to FD, which is extremely rare and
worthy of special remark.
FD can be divided into two major types: monostotic
and polyostotic [15]. According to the largest series, ma-
lignant changes seem more likely to occur in polyostotic
than in monostotic FD [13, 16]. It is consistent that the
current research described a malignant change in a
polyostotic FD. Although it is important to recognize
malignant transformation as early as possible, it may not
be easy as in our case. Suspecting from malignant
Fig. 2 a Histologic analysis of hematoxylin and eosin-stained specimens of the left femur showed irregularly shaped spicules of immature bone
without osteoblastic rimming and fibrous stroma with few mitotic activities, which consisted in the diagnosis of recurrence of FD of the left
femur. b The histologic analysis of specimens from the amputation consisted in the diagnosis of PMH secondary to FD of the left lower limb.
c Immunohistochemical analysis showed positive for CD31
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transformation can be extremely difficult especially in
cases with monostotic disease having either subtle symp-
toms or none. In the reported cases up to date, the spe-
cial symptoms of the malignant change were mainly
pain, swelling, and late appearance of a bony mass
[17, 18]. But given the fact that the pain is a nonspecial
finding and is the most common complaint followed by
pathological fracture in FD [19], great care should be
taken when evaluating this symptom. Pain which is rapidly
becoming worse over a relatively short period without
trauma should be considered alarming [17].
PMH is extremely difficult to diagnose because of no
morphological evidence suggestive of endothelial differ-
entiation is present to confirm a radiological pattern of
vascular neoplasm (multiple well-limited purely lytic le-
sions) [2]. The tumor is composed of large spindle cells,
arranged in sheets or fascicles. Tumor cells with epithe-
lioid cytomorphology are also often present. In this case,
the tumor consists of spindle cells, and round epithelioid
cells exist. The cells are large and have abundant eosino-
philic cytoplasm, mimicking a myoid tumor or epitheli-
oid carcinoma cells. The tumor cells are plump but
show no apparent pleomorphism. The nuclei of the
cells have small nucleoli without notable atypia, and the
mitotic activity is scarce.
Based on previous reports in other locations, PMH
has a more indolent clinical course with a small risk of
metastasis [2]. Therefore, complete macroscopic excision
is the treatment of choice. Local recurrence must be
considered, even with complete, gross surgical resection;
close follow-up and adjuvant therapy are warranted.
Conclusions
In conclusion, we present an extremely rare case of pseu-
domyogenic hemangioendothelioma secondary to fibrous
dysplasia. Pseudomyogenic hemangioendothelioma is a
rare endothelial neoplasm which often mimics myoid and
epithelioid tumors morphologically. For the diagnosis, the
immunostaining is very important but not decisive and
enough. Clinical information including age, gender, tumor
location, disease course, and recurrence is important for
appropriate diagnosis, and full understanding of the tumor
is indispensable. Analysis based on any single factor or in-
complete information may easily lead to arbitrary conclu-
sion. However, the reports of this tumor are limited.
Further studies on more cases are in need for the full un-
derstanding and appropriate diagnosis of it. An awareness
of the potential for PMH to present in this way is helpful
for both radiologists and pathologists when confronted
with this rare tumor. With regards to the present case, the
patient remained symptom-free 3 months after surgery.
Due to the risk of recurrence, and additional risk of
metastasis, long-term follow-ups should be continued.
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